CRP and depressive disorder: In the context of depressive disorders, findings from the GENDEP (genome-based therapeutic drugs for depression) study reveal that the levels of C-reactive protein can predict differential responses to pharmacotherapies such as nortriptyline and escitalopram, which have distinct pharmacological profiles [200].